DOCSLIB.ORG

Curriculum Vitae [PDF]

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae [PDF] CURRICULUM VITAE GYAN PAREEK, M.D. Academic Address: 2 Dudley Street, Suite 174 Providence, RI 02905 Academic Telephone Number: 401-444-8570 Academic Fax Number: 401-444-6947 Mobile Number: 401-537-7763 Electronic Mail Address: [email protected] EDUCATION Undergraduate: University of Pittsburgh, Pittsburgh, PA Bachelor of Science in Neuroscience, 1991 Graduate: Roswell Park Cancer Institute, SUNY at Buffalo Buffalo, NY Master of Science, 1993 Brown University Providence, RI Master of Arts ad eundem, 2014 Harvard Medical School Boston, MA 2018-Current Harvard Certificate in Leadership Medical School: St. George’s University School of Medicine, M.D., 1998 POSTGRADUATE TRAINING Residency: Lenox Hill Hospital, New York, NY Surgery (PGY1), 7/1/1998-6/30/1999 Lenox Hill Hospital, New York, NY Surgery (PGY2), 7/1/1999-6/2000 Lenox Hill Hospital, New York, NY Urology, 7/1/2000-6/30/2004 Fellowship: Laparoscopy and Endourology, University of Wisconsin, Madison, WI Clinical Instructor, 7/1/2004-6/30/2005 1 POSTGRADUATE HONORS AND AWARDS 2004 American Urological Association Pfizer Scholar 2005 Annual Essay Contest, Second Place, “Basic Science” and “Elastographic Measurements of In-Vivo Radiofrequency Ablation Lesions of the Kidney.” Endourological Society, Amsterdam, Netherlands 2006 Urology (Gold Journal) Essay Contest, Second Place, “Shockwave Lithotripsy Success Based on Skin to Stone Distance on Computed Tomography.” American Urological Association, Atlanta, Georgia 2009 The Dean’s Excellence in Teaching Award, “Urology Clinical Elective”, Alpert Medical School of Brown University 2011 The Dean’s Excellence in Teaching Award, “Urology Clinical Elective”, Alpert Medical School of Brown University 2014 The Dean’s Excellence in Teaching Award, “Doctoring”, Alpert Medical School of Brown University 2014 Awarded Master of Arts ad eundem Brown University 2014 Rhode Island Top Doctor – RI Monthly 2015 Rhode Island Top Doctor – RI Monthly 2015 Arthur and Joyce Hurvitz Quality Improvement Award The Miriam Hospital, Providence RI 1st Place 2016 The Miriam Hospital Foundation Grant Award on Proteonomic Analysis of Urine in Stone Formers 2017 Chosen Member of Team USA: TransAtlantic Leaders in Endourologic Technologies (TALENTS) (total team 25 urologists). 2 2019 Rhode Island Top Doctor – RI Monthly C.A.R.E. Award, The Miriam Hospital, Excellence in Patient Care Gold Award in Patient Care Reisman Family Teaching Award, The Miriam Hospital PROFESSIONAL LICENSES AND BOARD CERTIFICATION New York #227047 Issued: 12/5/02 – Inactive Wisconsin #46597 Issued: 3/10/04 – Inactive American Board of Urology Part I: 8/6/04 Part II: 3/16/07 MOC Recertification: 10/15/2015 (valid to 2027) Diplomate, ABU#15533 3/16/07, 1/2010, 10/2015 Rhode Island, MD#11734 Issued: 3/9/05 - Active ACADEMIC APPOINTMENTS 2004-2005 Clinical Instructor, Department of Surgery, Division of Urology, University of Wisconsin Medical School, Madison, Wisconsin. 2005-2012 Assistant Professor of Surgery (Urology), The Warren Alpert Medical School of Brown University, Providence, RI, 2005- 2013. 2012-present Associate Professor of Surgery (Urology), The Warren Alpert Medical School of Brown University, Providence, RI, 2013-2019. 2010-present Director, Endourology Fellowship (non-ACGME sub-specialty), The Warren Alpert Medical School of Brown University, Providence, RI 2010- present. 2019-present Professor of Surgery (Urology) and Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 2019-present 3 HOSPITAL APPOINTMENTS 2005- Present Rhode Island Hospital, Staff Urologist, Division of Urology 2005-Present Veterans Administration Hospital, 2005-present 2005-Present Women and Infants' Hospital, Providence, Consultant 2005-Present Memorial Hospital of Rhode Island, Courtesy Staff 2005-Present The Miriam Hospital, Consultant 2005-Present Hasbro Children’s Hospital 2007-Present Director: Minimally Invasive Urologic Surgery, Department of Surgery, Division of Urology, Rhode Island Hospital/The Miriam Hospital, Providence, RI 2013-Present Director: The Kidney Stone Center, The Miriam Hospital Providence, RI 2013-Present Co-Director: Minimally Invasive Urology Institute, The Miriam Hospital, Providence, RI OTHER APPOINTMENTS 2000-Present Journal Reviewer: Journal of Endourology 2005-Present Journal Reviewer: Journal of Urology 2005-Present Journal Reviewer: Urology 2005-Present Journal Reviewer: Canadian Journal of Urology 2005-Present Journal Reviewer: Journal of Pediatric Urology HOSPITAL COMMITTEES 1993 International Community Medicine – Peritoneal Dialysis Committee St. Vincent’s Hospital 1995 Co-Founder: Saint Vincent’s Heart Foundation 4 2000-2003 Lenox Hill Hospital Annual Urology Symposium Committee 2005- Present Rhode Island Hospital, Division of Urology, Continuing Medical Education Program Planning Committee, 2007-2011 Rhode Island Hospital, Operating Room Committee 2007-2014 The Miriam Hospital, Robotic Surgery Steering Committee 2009-2014 Chairman Education Committee, Rhode Island Hospital/The Miriam Hospital, Division of Urology 2014-2017 Chairman Program Evaluation Committee, Rhode Island Hospital/The Miriam Hospital, Division of Urology 2012-2014 Rhode Island Hospital, Surgical Clinical Practice & Safety Committee 2013-2017 Clinical Competency Committee, Rhode Island Hospital/The Miriam Hospital, Division of Urology 2014-Present Clinical Quality Council, The Miriam Hospital 2014-Present Min Inv Urology Institute Governance Committee, Miriam Hospital 2014-2016 Operations Committee, Rhode Island Medical Group 2017-Present Brown Physicians Inc (BPI) Clinical Practice/Operations Committee UNIVERSITY COMMITTEES 1990 HIV/AIDS Research Committee, University of Pittsburgh 1994-1995 Assistant Director of Non-Academic Student Affairs, St. George’s University School of Medicine 1999-2010 Admissions Committee, Saint George’s University School of Medicine 2011- Present Admissions Committee, Alpert Medical School of Brown University MEMBERSHIP IN SOCIETIES 5 1998-Present American Urological Association Laparoscopy and New Technology Committee, 2011-2018 Abstract Review Committee 2014-Present 1998- Present American Medical Association 1998-Present Endourology Society, 1998 to present Web-site Committee, 2010-2014 2005- Present American Urological Association New England Section Scientific Program Committee. New England Section, 2010.2011,2014 Co-Chairman, Scientific Program Committee (2010) Board Member, RI Representative to NEAUA 2015-17 Socio-economics Committee NEAUA 2015-17 2005-Present American Association of Clinical Urologists 2005-Present Society of Urology and Engineering 2005-Present Rhode Island Urological Society, President, 2011-present 2007-Present Society of Laparoendoscopic Surgeons 2009-Present Rhode Island Medical Society 2012-Present Fellow American College of Surgeons 2016-Present Research on Calculus Kinetics (ROCK) Society 2017-Present Blue Cross Blue Shield Corporation Board Member OTHER 2010-Present Friends of Shelter Associates, co-founder (focus on sanitizing third world countries, www.friendsofsa.org) 2008-2017 Board Member: University Urology Associates, Inc., Providence, RI 2018-Present Board Member: Brown Urology, Inc Providence, RI 2008-Present Medical Director: Bay Area Mobile Medical, Providence, RI 2018-Present Vice-President of Operations, Brown Urology Inc. 6 2018-Present Vice President of Operations, Brown Urology, Inc ORIGINAL PUBLICATIONS IN PEER-REVIEWED JOURNALS 1. Pareek G, Armenakas NA, Fracchia JA. Periprostatic nerve blockade for transrectal ultrasound guided biopsy of the prostate: A randomized double-blind, placebo controlled study. J Urol 2001; 166(3):894-7. 2. Pareek G, Specht M, Lin DD, Petratos PB, Fahey TH, Soslow RA, Felsen D, Poppas DP. Hand-assisted demucosalized gastrocystoplasty comparing different tissue closure methods. Urol 2001; 58(4):625-30. 3. Hochberg DA, Basillote JB, Armenakas NA, Vasovic L, Shevchuk M, Pareek G, Fracchia JA. Decreased suburethral prostatic microvessel density in finasteride treated prostates: A possible mechanism of reduced bleeding in benign prostatic hyperplasia. J Urol 2002; 167(4):1731-3. 4. Specht M, Pareek G, Lin DD, Bleustein C, Fahey TJ, Felsen D, Poppas DP. Hand-assisted laparoscopic autoaugmentation gastrocystoplasty. Surg. Endosc 2002; 16(11):1538-41. 5. Pareek G, Shevchuk M, Armenakas NA, Vasjovic L, Hochberg DA, Basillote JB, Fracchia JA. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: A possible mechanism for decreased prostatic bleeding in treated patients. J Urol 2003; 169(1):20-3. 6. Pareek G, Armenakas NA, Fracchia JA. Hounsfield units on computerized tomography predict stone-free rates after extracorporeal shock wave lithotripsy. J Urol 2003; 169(5):1679-81. 7. Armenakas NA, Pareek G, Fracchia JA. Iatrogenic bladder perforations: Long-term follow- up of 65 patients. J Am Coll Surg 2004; 198(1):78-82. 8. Pareek G, Shevchuk M, Armenakas NA, Fracchia JA. The effect of BCG on angiogenesis and cellular proliferation in recurrent transitional cell carcinoma of the bladder. Uro Oncology 2004; 4(1):31-4. 9. Bruno JJ II, Pareek G, Armenakas NA, Plawner J, Fracchia JA.: Perioperative advantage of radical perineal prostatectomy over radical retropubic prostatectomy. UroOncology 2004; 4(3-4):127-9. 7 10. Pareek G, Armenakas NA, Panagopoulos G, Bruno JJ, Fracchia JA. Extracorporeal shock wave lithotripsy success based on body mass index and Hounsfield units. Urology 2005; 65(1):33-6. 11. Pareek G and Nakada SY. Current
Load more

Recommended publications
  • 2017 Annual Report Rhode Island Hospital : the Miriam
    Rhode Island Hospital The Miriam Hospital Newport Hospital Cancer Program Annual Report 2017 Report of the Cancer Committee _________________________________________________________________________________________________ 2017 Annual Report Rhode Island Hospital : The Miriam Hospital : Newport Hospital Content 1.0 Introduction & Goals 3 2.0 2017 Cancer Committee Membership List 5 3.0 Cancer Program Statistics 3.1 2016 Analytic Primary Site Distribution 7 3.2 Top Ten Sites and Residence at Diagnosis 9 3.3 Gender by Age and Stage of Disease at Diagnosis 10 3.4 Cancer Program Practice Profile Report (CP3R) 11 3.5 Community Outreach – Prevention & Screening Program 13 4.0 Colon Cancer Outcome Analysis 4.1 Risk Factors and Symptoms 14 4.2 NCDB Colon Case Distribution by Year 15 4.3 NCDB Comparison Report by Race and S.E.E.R Race Distribution 16 4.4 NCDB Comparison Report by Age and S.E.E.R. Age Distribution 17 4.5 Histology Distribution 18 4.6 Screening Techniques & AJCC Stage 19 4.7 NCDB Comparison Report by Stage and Program Stage 20 Distribution 4.8 Colorectal Cancer Treatment 21 4.9 NCDB Comparison Report by Treatment 22 4.10 Quality Oncology Practice Initiative (QOPI) – Colon Results 23 Spring 2017 4.11 Summary 24 Page 2 of 24 Introduction In August 2013, the cancer programs at Rhode Island Hospital, The Miriam Hospital, and Newport Hospital officially merged into one, system-wide Integrated Network Cancer Program. The mission of the program is to provide patient centered, research focused, high quality, high value care that is consistent across our network. The Lifespan Cancer Institute a Program of Rhode Island Hospital, brings together world- renowned physicians whose level of knowledge and experience are unparalleled in Rhode Island.
    [Show full text]
  • Prospectus Symp19-8-2019.Indd
    EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS TH INTERNATIONAL PROSTATE CANCER AND UROLOGIC ONCOLOGY SYMPOSIUM NOVEMBER 7-9, 2019 NEW YORK, NY MOUNTSINAIUROLOGYCME.ORG HIGHLIGHTS • Over 100 world-renowned faculty • Engaging point-counterpoint debates and • Live 3-D surgical demonstrations, including panel discussion prostate, kidney, bladder procedures • Global exposure with international web streaming of select sessions and events Welcome to the Fourth International Prostate Cancer and Urologic Oncology Symposium. EDUCATIONAL HIGHLIGHTS • Live 3-D surgery transmission covering complex urologic surgery • Comprehensive didactic lectures from the world’s leading experts in urologic oncology • Robust review of the latest advances in surgical techniques and management of prostate, kidney, and bladder cancer • Personal interaction with world-class faculty • Stimulating point-counterpoint debates on timely topics DAILY HIGHLIGHTS PROSTATE DAY 1 THUR. 11/7/19 PROSTATE DAY 2 FRI. 11/8/19 KIDNEY & BLADDER SAT. 11/9/19 • Advanced imaging in genomics • Innovations in the management of • New progress in pre-operative and for prostate cancer castrate-sensitive prostate cancer intra-operative imaging, 3-D • Biomarkers and immunotherapy modelling, and ultra sound • Focus on radiomics and guidance for renal tumors radiogenomics • Update on clinical trials for castrate-resistant treatments for • Novel therapeutics in the • Utility of imaging and artificial prostate cancer management of metastatic renal intelligence in prostate cancer cell carcinomas:
    [Show full text]
  • In the News September 30, 2016
    From: ITNDaily on behalf of Werle, Laura Subject: Mount Sinai In the News - September 30, 2016 Date: Friday, September 30, 2016 2:06:09 PM Attachments: ATT00002.txt In the News September 30, 2016 Nature – September 30 Inflammation in Patients With Cushing Disease — Claire Greenhill Circulating levels of proinflammatory cytokines are increased in patients with Cushing disease, both during active disease and after remission, according to new data published in Clinical Endocrinology. These findings demonstrate that cytokine levels are increased in patients after remission of Cushing disease, which could explain the persistent increased risk of cardiovascular-related death. The study, led by Eliza Geer, MD, a professor of endocrinology at the Icahn School of Medicine at Mount Sinai, notes that more studies are needed to determine why levels of IL-6 and IL-1β remain elevated after remission of Cushing disease. - Eliza Geer, MD, Associate Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Neurosurgery, Icahn School of Medicine at Mount Sinai Learn more: http://www.nature.com/nrendo/journal/vaop/ncurrent/full/nrendo.2016.170.html WCBS – September 29 ‘Artificial Pancreas’ Expected To Make Life Easier, Healthier For Type 1 Diabetes Patients — Max Gomez A groundbreaking new device could change the lives of millions of people living with diabetes. Federal regulators just approved an artificial pancreas that can monitor and administer insulin. The key is a computer algorithm that does those calculations faster and more accurately than a patient can. “It looks at the numbers from a moment to moment basis, and it will proactively predict what is going to happen next and make clinical decisions that cannot be done at that rate.
    [Show full text]
  • In the News July 29, 2016
    From: ITNDaily on behalf of Stephanie Sherman Subject: Mount Sinai In The News - July 29, 2016 Date: Friday, July 29, 2016 11:20:39 AM Attachments: ATT00002.txt In the News July 29, 2016 WBUR News – July 28 Doctors Need A New Skill Set For This Opioid Abuse Treatment — Karen Shakerdge Braeburn Pharmaceuticals, the company behind the newly FDA-approved treatment Probuphine, is teaching doctors how to use it. Although addiction specialists welcome Probuphine, which delivers a constant dose of the drug buprenorphine over six months, at this early stage it's complicated for physicians to add it to their repertoire. Patients using Probuphine were 14 percent more likely to stay opioid-free compared to those using a daily sublingual version of buprenophine, according to a study published this month in JAMA, the Journal of the American Medical Association. So it's good to have another way to deliver medication-assisted treatment, says Richard Rosenthal, medical director of addiction psychiatry for the Mount Sinai Health System. Rosenthal was one of two principal investigators on a Probuphine clinical trial. "Everybody is waking up to the fact that we're in the midst of an opioid epidemic," says Rosenthal. "There are actually very few medications for addiction of any kind. Given the addiction treatment system in the United States, most of the treatment that's given is psychosocial. There's very little use of FDA-approved medications." - Richard N. Rosenthal. MD, Professor, Psychiatry, Mount Sinai West Learn more: http://www.wbur.org/npr/487080738/doctors-need-a-new-skill-set-for-this-opioid-abuse- treatment MD Alert – July 28 Some Non-Celiac Gluten Sensitivity Patients May Have 'Celiac Lite' Disease — Marilynn Larkin A subset of patients with non-celiac gluten sensitivity (NCGS) may actually have a form of celiac disease, researchers in Spain report.
    [Show full text]
  • The Rules and Regulations of the Rhode Island Hospital
    THE RULES AND REGULATIONS OF THE RHODE ISLAND HOSPITAL MEDICAL STAFF Adopted: April 26, 2012 Approved: June 7, 2012 Implemented: July 1, 2012 MEDICAL STAFF RULES AND REGULATIONS TABLE OF CONTENTS SECTION PAGE Preamble 3 I. Admission of Patients 3 II. Transfer of Patients 5 III. Discharge of Patients 6 IV. Criteria for Autopsy 6 V. Medical Records 7 VI. General Conduct of Care 13 VII. General Rules Regarding Surgical Care 14 VIII. General Rules Regarding Emergency Services 17 IX. Miscellaneous 19 X. Committees 19 FINAL 0512 Page 2 of 24 MEDICAL STAFF RULES AND REGULATIONS PREAMBLE The following Rules and Regulations for the Rhode Island Hospital Medical Staff (the “Medical Staff”) describe specific policies and procedures of the Medical Staff and define in greater specificity, provisions of the Medical Staff Bylaws. All members of the Medical Staff are expected to comply with the provisions contained in these Rules and Regulations and to follow the Rhode Island Hospital (the “Hospital”) values of respect for every individual and a commitment to quality services. These Rules and Regulations of the Medical Staff are designed to augment and/or clarify requirements related to clinical practice at the Hospital. Care is also governed by federal and state statutes and regulations; standards and conditions of accreditation organizations; the Conditions of Participation of the Centers for Medicare and Medicaid Services (CMS); and Hospital policies and procedures. Where conflicts in requirements arise, these Rules and Regulations are superseded by external regulatory requirements. When conflicts exist between regulatory agency requirements, the more stringent requirement is followed. The Rules and Regulations of the Medical Staff must conform to federal and state requirements, but they may also have additional requirements as set forth by the Medical Staff and the Hospital’s Board.
    [Show full text]
  • Intern Recruitment Campaign
    Intern Recruitment Frequently asked questions (FAQs) Cairns and Hinterland Hospital and Health Service Intern Recruitment - Frequently asked questions (FAQs) Contents CORE TERMS 4 TERMS for PGY2 5 ACCREDITED TRAINING POSITIONS 6 ROTATIONS 6 RURAL/COUNTRY RELIEVING 6 REMOTE CALL 6 WARD CALL 6 EDUCATIONAL SESSIONS 7 SUPPORT FOR INTERNS 8 WORKLOAD and OVERTIME 9 NIGHT DUTY 9 LEAVE 9 LEAVE IN ADVANCE 10 RELOCATION 9 ACCOMMODATION 10 PART-TIME or JOB-SHARE 10 LATE START 11 SWAPPING or TRANSFERS 11 INTERN: CONSULTANT RATIO 11 Intern Recruitment - Frequently asked questions (FAQs) Cairns and Hinterland Hospital and Health Service Page 2 FACILITY BENEFITS 11 CAR PARKING 12 LIFESTYLE OFFER 12 CONTACTS 13 Intern Recruitment - Frequently asked questions (FAQs) Cairns and Hinterland Hospital and Health Service Page 3 CORE TERMS What core and elective terms does your facility offer PGY1? Compulsory Terms Non-Compulsory Terms • Emergency Medicine • Obstetrics and Gynaecology • General Medicine/MAU • Paediatrics : limited availability • General Medicine-Renal • General Medicine-Gastroenterology • General Medicine- Thoracic • General Medicine- Acute Geriatrics • General Orthopaedics • ICU: limited availability • General Surgery • General Orthopaedics/ General Surgery • Mental Health • Atherton Hospital • Sexual Health • Mareeba Hospital • Cardiology • Infectious Diseases • Endocrinology • Rehabilitation cont. Intern Recruitment - Frequently asked questions (FAQs) Cairns and Hinterland Hospital and Health Service Page 4 Compulsory Terms Non-Compulsory
    [Show full text]
  • Program Book Welcome Message
    E M A D I C C A U F R O O L Y O T G E I I S C T O S S 20 16 2018 SAU Program Directors, Coordinators & Academicians Meeting February 8 – 10, 2018 Miami Marriott Dadeland | Miami, Florida Program Committee: Gary J. Faerber, MD University of Utah Urology Louis R. Kavoussi, MD Hofstra Northwell School of Medicine JOINTLY PROVIDED BY: Creighton University Health Sciences Continuing Education and the Society of Academic Urologists 2018 PROGRAM BOOK WELCOME MESSAGE Welcome! I am excited that Miami, Florida is the venue for the Some of the topics include: 2018 SAU Program Directors, Coordinators & Academicians Meeting. This is our second annual educational meeting • New Common Program Requirements for both sponsored by the SAU. The reason we host the SAU General and Pediatric Urology Program Directors, Coordinators & Academicians Meeting • Inner Workings of the RRC: Procedures and is so that we can train the next generation of urologists Processes in this country. The ACGME challenges us every day to conceive of ways to incorporate the changing landscape • Resident Remediation of medicine into practical, bite-sized bits for our trainees. • Possible Changes to the Current Training Model Although it seems that the principles of teaching never • Changing the Current AUA Match change, the evolution in the expectations of teaching have - and will continue to change. The world has shifted, as most • Attracting Women and Minorities in Urology things do, with the change in and application of knowledge and technologies. It is an exciting – and exhausting time. During the educational workshop there will be many other Change always involves a bit of both.
    [Show full text]
  • PARTNERSHIP PROSPECTUS SEPTEMBER MOUNT SINAI HOSPITAL 7-9 NEW YORK, NEW YORK 2017 Second International Urologic Cancer Symposium
    EXHIBITOR AND PROMOTIONAL PARTNERSHIP PROSPECTUS SEPTEMBER MOUNT SINAI HOSPITAL 7-9 NEW YORK, NEW YORK 2017 Second International Urologic Cancer Symposium HIGHLIGHTS • Over 80 renowned global faculty • Live 3D surgical demonstrations, including prostate, kidney, bladder and reconstruction • Point-Counterpoint Debate • Annual Push Up Challenge • Gala to Raise Funds for Urologic Cancer Research TOPIC AREAS • Screening and Low Risk Disease • Localized Prostate Cancer • Biomarkers and Genomics • Advanced Prostate Cancer • Immunotherapy • Kidney Cancer • Focal Therapy • Bladder Cancer www.mountsinaiurologycme.org TABLE OFCONTENTS Invitation to Exhibit/Sponsor . 1 Department of Urology 75th Anniversary Session . 2 Screening & Low Risk Disease . 3 Focal Therapy . 4 Treatment Failure . 4 Immunotherapy & Tumor Microenvironment . 5 Radical Prostatectomy . 6 Treating Localized Disease . 7 Advanced Prostate Cancer . 8 Locally Advance Disease. 9 Quality of Life . 9 Kidney Cancer - I. 10 Kidney Cancer - II . 11 Kidney Cancer - III . 12 Bladder Cancer I . 13 Partnership Information . 14 Partnership Opportunities . 15 Exhibit Registration Form . 17 Agenda. 18 Invitation to Exhibit/Sponsor 1 Course Director Dear Industry Colleagues: Ash Tewari, MBBS, MCh On behalf of the Department of Urology at the Icahn School of Medicine at Mount Sinai Hospital in New York City, I Co –Directors would like to invite you to partner with the 2nd International Urologic Cancer Symposium being held on September On behalf of the Department of Urology at the Icahn School of Medicine at Mount Sinai Hospital in New Ketan K. Badani, MD 6-9, 2017 at the Mount Sinai School of Medicine in New York, NY. Ranked among the nation’s best for Urology York City, I would like to invite you to partner with the Second International Prostate Cancer Nina Bhardwaj, MD, PhD in the 2016-2017 "Best Hospitals" issue of U.S.
    [Show full text]
  • Donald R. Coustan CV Last Updated 17 Nov18 Page 1
    Donald R. Coustan CV Last updated 17 Nov18 CURRICULUM VITAE Name: Donald Ross Coustan, MD Born: Chicago, Illinois - October 18, 1943 Wife: Terri Distenfield Coustan Children: Rebecca, Rachel, David Home Address: 265 Seaside Drive Jamestown, RI 02835 401-423-2277 Business Address: Women & Infants Hospital of Rhode Island Maternal-Fetal Medicine Division 101 Dudley Street Providence, RI 02905-2401 401-274-1100, Extension 47452 Education and Training: Yale College, B.A. in Psychology (Magna Cum Laude), 1964. Yale Medical School, M.D., 1968 Internship: Straight Internal Medicine, Yale-New Haven Medical Center, 1968-1969 Residency: Obstetrics and Gynecology, Yale-New Haven Medical Center, 1969-1973 Professional Experience: Instructor in Obstetrics and Gynecology, Yale University School of Medicine, 1972-1973 Lieutenant Commander, Chief of Obstetrics, Naval Regional Medical Center, Oakland California, 1973-1975 Assistant Professor of Obstetrics and Gynecology, Yale University School of Medicine, 1975-1980 Director, Diabetes in Pregnancy Program, Yale University School of Medicine, 1975-1982 Attending Perinatologist, High Risk Pregnancy Program, Yale-New Haven Medical Center, 1975-19 Associate Professor of Obstetrics and Gynecology, Yale University School of Medicine, 1980-1982 Associate Professor of Obstetrics and Gynecology, Brown University Program in Medicine, 1982-1986 Director, Division of Maternal-Fetal Medicine, Women & Infants Hospital of Rhode Island, 1982-1991 Professor of Obstetrics and Gynecology, Brown University Program in Medicine,
    [Show full text]
  • Program Book
    2019 SAU Program Directors, Coordinators & Academicians Meeting February 1 – 2, 2019 JW Marriott Houston Galleria Houston, Texas PROGRAM BOOK Program Chairs: Kirsten Greene, MD, MS University of California, San Francisco Moben Mirza, MD, FACS University of Kansas Medical Center Jointly Provided By: Creighton University Health Sciences Continuing Education and the Society of Academic Urologists WELCOME MESSAGE Welcome Program Directors, Coordinators and Academicians, I am excited to see all of you in Houston for the 2019 SAU Program Directors, Coordinators & Academicians Meeting. This is our third annual winter meeting, and we anticipate another strong and dynamic conference! Each year we hold this meeting to address issues in residency training and propose solutions so that future generations of urologists receive the training they need and deliver our patients continually better care. This year, the meeting has been reduced from three days to two in order to minimize time spent out of the office, and maximize the educational value of the program. Houston, Texas is also a great, central location that is easy to travel to from all over the country. I also welcome the opportunity for some warmer weather in February. I want to first thank Drs. Kirsten Greene and Moben Mirza for volunteering to be the co-chairs for the 2019 meeting. They have developed a tremendous curriculum that will bring value to all of us who practice in academic urology. Notable sessions include: • How to Comply with Section VI of the Common Program Requirements • Review of the PGY-1 Year Curriculum • Self-Study Site Visits • Resident Debates on Well-being, Burnout and Morale Building • Career Development and Success We’re also thrilled to have Dr.
    [Show full text]
  • Heartbeats Magazine
    Fall 2014 HeartbeatsMagazine SurgerySurgery atat IslandIsland pp 1212 In-Home Relief for Your Care Pain p 9 p 5 Commissioner’s Message Kathy Garde MD elected Check facility prior to any IH Chief of Medical Staff athleen A. Garde MD, an obstetrics and surgical procedure Kgynecology specialist, has been elected to serve as Chief of Medical Staff at Island Hospital. by Chip Bogosian MD During the 2015-2017 term, her duties will Commissioners include maintaining high-quality patient care; oan Rivers, one of my favorite come- working with medical staff, hospital employees Jdians, recently died in New York after and Administration to provide first-rate health- a “minor” and “routine” throat procedure care services and acting as a liaison between Kathy Garde MD because she “stopped breathing”. This didn’t Medical Staff and the community. make sense to me since as an anesthesiolo- Dr. Garde received a Bachelors degree from Seton Hill University, gist I have stopped literally thousands of Greensburg, PA and Masters and Doctorate of Medicine degrees from patients from breathing without this horrif- Case Western Reserve University School of Medicine, Cleveland, OH. ic result, so I looked further. She completed an internship and a residency in Obstetrics and Chip Bogosian MD It turns out that Ms. Rivers entered the Gynecology at Mt. Sinai Medical Center, Cleveland, where she Yorkville Endoscopy Clinic in New York City received advanced training in urogynecology, a medical subspecialty for a simple procedure on her vocal cords, which would require a dedicated to the treatment of women with pelvic-floor disorders. number of different anesthesia techniques to provide the optimal Prior to joining Fidalgo Medical Associates in 2001, Dr.
    [Show full text]
  • HEMATOLOGY-ONCOLOGY Overview
    HEMATOLOGY- ONCOLOGY HEMATOLOGY-ONCOLOGY Overview The Brown University/Lifespan Hematology/ Oncology group was formed when The Miriam Hospital Hematology/Oncology Division, the Rhode Island Hospital Division of Hematology and the Rhode Island Hospital Department of Medical Oncology merged in 1999. Our mission is to achieve academic excellence in basic research, clinical research and education, and to provide the highest quality of care to our patients. The creation of a Comprehensive Cancer Center, which is a collaborative effort to provide coordi- nated and comprehensive care for cancer patients at three Lifespan hospitals (The Miriam Hospital, Rhode Island Hospital and Newport Hospital), has now become a reality. Both the patients and the staff appreciate the many benefits afforded by the new Comprehensive Cancer Center at The Miriam Hospital which opened in May 2002. Extensive renovations to the George Clinic at Rhode Island Hospital were completed as a temporary measure. The groundbreaking ceremony for the Comprehen- sive Cancer Center at Rhode Island Hospital was held on April 28, 2003 with an anticipated opening in February 2004. A recent goal has been the establishment of multi- disciplinary clinics for all the major malignancies. This conveniently allows the patient to receive the Edward Wittels, M.D., Associate Professor of expertise of the surgeon, radiation oncologist and Medicine; Interim Director of Hematology- medical oncologist at the time of their first visit. Oncology and Interim Director of medical Presently, upper GI and melanoma multidisciplinary Oncology Division at Brown Medical School clinics are up and running at Rhode Island Hospital. A thoracic multidisciplinary tumor board has been implemented at each hospital.
    [Show full text]